Butoconazole Nitrate

硝酸布康唑

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameButoconazole Nitrate
Drug Alias Namebutoconazolum布康唑硝酸盐butoconazolebutoconazolMycelex-3 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsCandidiasis, VulvovaginalCandidiasis
Global Approved IndicationsCandidiasis
Approved Indications in ChinaCandidiasis
Original Approved Country/TerritoryUnited States
Original Approved Date1995/12/21
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesKv Pharmaceutical CompanyJinan Hongrui Chuangbo Pharmaceutical Technology Development Co Ltd
Inactive CompaniesEmsBayer AGYangtze River Pharmaceutical (Group) Co Ltd +[4] 
Active IndicationsCandidiasis, VulvovaginalCandidiasis
Inactive IndicationsN/A

Other Information

ATC CodeG01AF15
Related LinksWikipediaDrugBankKEGG